Molecular dynamics simulations revealed that luteolin induced conformational changes in MAPK1 and PIK3CA, driven by the non-covalent bonding interactions of luteolin in its optimal conformational position within the binding pocket, affecting their functions in BC progression. The gene discussed is MAPK1; the disease is breast cancer.